Literature DB >> 9547472

Use of clozapine in 10 mentally retarded adults.

R D Buzan1, S L Dubovsky, D Firestone, E Dal Pozzo.   

Abstract

The cost, side effect profile, and required weekly blood draws associated with clozapine may dissuade some clinicians from prescribing this atypical neuroleptic to mentally retarded patients. All publications on clozapine use in mentally retarded patients are reviewed and the treatment of 10 such patients is described, bringing the total number of published cases to 84. Clozapine is efficacious and well tolerated in this population and should be considered for those patients with psychosis or bipolar illness who are intolerant of or unresponsive to other agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547472     DOI: 10.1176/jnp.10.1.93

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  4 in total

1.  Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation.

Authors:  R Hammock; W R Levine; S R Schroeder
Journal:  J Autism Dev Disord       Date:  2001-02

Review 2.  Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.

Authors:  R Antochi; C Stavrakaki; P C Emery
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

Review 3.  Diagnosis and treatment of mood disorders in adults with developmental disabilities.

Authors:  Diana J Antonacci; Nadir Attiah
Journal:  Psychiatr Q       Date:  2008-08-23

Review 4.  Clozapine for psychotic disorders in adults with intellectual disabilities.

Authors:  Muhammad Ayub; Khalid Saeed; Tariq A Munshi; Farooq Naeem
Journal:  Cochrane Database Syst Rev       Date:  2015-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.